A Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group, Pilot Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Relapsing-remitting Multiple Sclerosis
Phase of Trial: Phase IV
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms OPTIONS
- Sponsors Mallinckrodt Inc.
- 22 Sep 2017 Planned End Date changed from 1 Aug 2018 to 1 Sep 2018.
- 22 Sep 2017 Planned primary completion date changed from 1 Aug 2018 to 1 Sep 2018.
- 23 May 2017 According to a Mallinckrodt plc media release, first patient has been enrolled.